These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33738842)

  • 1. Optimal planning of adaptive two-stage designs.
    Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
    Stat Med; 2021 Jun; 40(13):3196-3213. PubMed ID: 33738842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
    Herrmann C; Pilz M; Kieser M; Rauch G
    Stat Med; 2020 Jul; 39(15):2067-2100. PubMed ID: 32249968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size recalculation in three-stage clinical trials and its evaluation.
    Bokelmann B; Rauch G; Meis J; Kieser M; Herrmann C
    BMC Med Res Methodol; 2024 Sep; 24(1):214. PubMed ID: 39322963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of adaptive designs with respect to a performance score.
    Herrmann C; Kieser M; Rauch G; Pilz M
    Biom J; 2022 Aug; 64(6):989-1006. PubMed ID: 35426460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoothing Corrections for Improving Sample Size Recalculation Rules in Adaptive Group Sequential Study Designs.
    Herrmann C; Rauch G
    Methods Inf Med; 2021 May; 60(1-02):1-8. PubMed ID: 33648007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension of a conditional performance score for sample size recalculation rules to the setting of binary endpoints.
    Bokelmann B; Rauch G; Meis J; Kieser M; Herrmann C
    BMC Med Res Methodol; 2024 Jan; 24(1):15. PubMed ID: 38243169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving sample size recalculation in adaptive clinical trials by resampling.
    Herrmann C; Kluge C; Pilz M; Kieser M; Rauch G
    Pharm Stat; 2021 Nov; 20(6):1035-1050. PubMed ID: 33792167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variational approach to optimal two-stage designs.
    Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
    Stat Med; 2019 Sep; 38(21):4159-4171. PubMed ID: 31264243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the efficiency of adaptive sample size design.
    Cui L; Zhang L
    Stat Med; 2019 Mar; 38(6):933-944. PubMed ID: 30450621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.
    Collignon O; Koenig F; Koch A; Hemmings RJ; Pétavy F; Saint-Raymond A; Papaluca-Amati M; Posch M
    Trials; 2018 Nov; 19(1):642. PubMed ID: 30454061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints.
    Meis J; Pilz M; Bokelmann B; Herrmann C; Rauch G; Kieser M
    Stat Med; 2024 Apr; 43(8):1577-1603. PubMed ID: 38339872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-stage designs for cross-over bioequivalence trials.
    Kieser M; Rauch G
    Stat Med; 2015 Jul; 34(16):2403-16. PubMed ID: 25809815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements.
    Boessen R; van der Baan F; Groenwold R; Egberts A; Klungel O; Grobbee D; Knol M; Roes K
    Pharm Stat; 2013; 12(6):366-74. PubMed ID: 24214896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradigms for adaptive statistical information designs: practical experiences and strategies.
    Wang SJ; Hung HM; O'Neill R
    Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal adaptive group sequential design with flexible timing of sample size determination.
    Cui L; Zhang L; Yang B
    Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal flexible sample size design with robust power.
    Zhang L; Cui L; Yang B
    Stat Med; 2016 Aug; 35(19):3385-96. PubMed ID: 26999385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal adaptive single-arm phase II trials under quantified uncertainty.
    Kunzmann K; Kieser M
    J Biopharm Stat; 2020; 30(1):89-103. PubMed ID: 31023135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal adaptive two-stage designs for early phase II clinical trials.
    Shan G; Wilding GE; Hutson AD; Gerstenberger S
    Stat Med; 2016 Apr; 35(8):1257-66. PubMed ID: 26526165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended two-stage adaptive designs with three target responses for phase II clinical trials.
    Kim S; Wong WK
    Stat Methods Med Res; 2018 Dec; 27(12):3628-3642. PubMed ID: 28535716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.